- Liquiritigenin decreases tumorigenesis by inhibiting DNMT activity and increasing BRCA1 transcriptional activity in triple-negative breast cancer
Fang Liang et al, 2021, Experimental Biology and Medicine CrossRef - Epigenetic therapy for the treatment of epithelial ovarian cancer: A clinical review
Haller J. Smith et al, 2017, Gynecologic Oncology Reports CrossRef - Aberrant promoter methylation of cancer-related genes in human breast cancer
Liang Wu et al, 2016, Oncology Letters CrossRef - Epigenetic modulations in cancer: predictive biomarkers and potential targets for overcoming the resistance to topoisomerase I inhibitors
Moustafa M. Madkour et al, 2023, Annals of Medicine CrossRef - DNA repair gene expressions are related to bone marrow cellularity in myelodysplastic syndrome
Howard L Ribeiro et al, 2017, Journal of Clinical Pathology CrossRef - Detection of hypermethylation BRCA1/2 gene promoter in breast tumours among Moroccan women
Imane Saif et al, 2021, Molecular Biology Reports CrossRef - Constitutional BRCA1 and MGMT Methylation Are Significant Risk Factors for Triple-Negative Breast Cancer and High-Grade Serous Ovarian Cancer in Saudi Women
Nisreen Al-Moghrabi et al, 2024, International Journal of Molecular Sciences CrossRef - Combined BRCA2 and MAGEC3 Expression Predict Outcome in Advanced Ovarian Cancers
Emmanuel B. Omole et al, 2022, Cancers CrossRef - Immunohistochemistry for the detection of BRCA1 and BRCA2 proteins in patients with ovarian cancer: a systematic review
Lorena Alves Teixeira et al, 2020, Journal of Clinical Pathology CrossRef - BRCA1 promoter hypermethylation in human placenta: a hidden link with β-hCG expression
Revathy Nadhan et al, 2020, Carcinogenesis CrossRef - Platinum-resistant ovarian cancer: From drug resistance mechanisms to liquid biopsy-based biomarkers for disease management
Mohammad Aslam Khan et al, 2021, Seminars in Cancer Biology CrossRef - Immunohistochemical expression of DNA methyltransferases 1, 3a, and 3b in actinic cheilitis and lip squamous cell carcinomas
Filipe I. Daniel et al, 2016, Journal of Oral Pathology & Medicine CrossRef - Prevalence of tumor BRCA1 and BRCA2 dysfunction in unselected patients with ovarian cancer
Roshni D. Kalachand et al, 2020, Obstetrics & Gynecology Science CrossRef - BRCA1Promoter Methylation and Clinical Outcomes in Ovarian Cancer: An Individual Patient Data Meta-Analysis
Roshni D Kalachand et al, 2020, JNCI: Journal of the National Cancer Institute CrossRef - Evaluation of promoter hypermethylation of tumor suppressor gene BRCA1 in epithelial ovarian cancer
DnyaneshB Amle et al, 2022, Journal of Cancer Research and Therapeutics CrossRef - Homologous recombination deficiency status-based classification of high-grade serous ovarian carcinoma
Hisamitsu Takaya et al, 2020, Scientific Reports CrossRef - Resveratrol modulates epigenetic regulators of promoter histone methylation and acetylation that restores BRCA1, p53, p21CIP1 in human breast cancer cell lines
Biji Chatterjee et al, 2019, BioFactors CrossRef - Methylation Status and Immunohistochemistry of BRCA1 in Epithelial Ovarian Cancer
Heru Pradjatmo et al, 2014, Asian Pacific Journal of Cancer Prevention CrossRef - ZC3H18 specifically binds and activates the BRCA1 promoter to facilitate homologous recombination in ovarian cancer
Arun Kanakkanthara et al, 2019, Nature Communications CrossRef